Jeremy Mottram


Jeremy Mottram is Professor in Pathogen Biology and director of the York Biomedical Research Institute. He trained as a biochemist at the University of Kent at Canterbury (BSc) and the University of Glasgow (PhD) before carrying out postdoctoral work at the University of California San Francisco in molecular parasitology, with a focus on gene expression and RNA splicing in African trypanosomes.  He returned to Glasgow for further postdoctoral research in the newly formed Wellcome Unit of Molecular Parasitology, before developing an independent molecular parasitology research programme as an MRC Senior Research Fellow (1993-2003), being appointed Professor of Molecular and Cellular Parasitology in 2000.  In Glasgow Jeremy served as Head of the Division of Infection and Immunity (2008-2010), Deputy Director of the Institute of Infection, Immunity and Inflammation (2010-2013) and Dean of Graduate Studies (2013–2015). He joined the Department of Biology at the University of York in 2016. He has been a member of the MRC Infections and Immunity Board (2010–2014) and has been on both national and international review boards for the Institute Pasteur, INSERM and NIMR. Jeremy is a Fellow of the Royal Society of Edinburgh, a Fellow of the Royal Society of Biology and a Pesquisador Visitante Especial, Universidade Federal do Rio de Janeiro, Brazil.

Nathaniel Jones


Nathaniel is a GCRF NTD Network Research Fellow. He is working to validate epigenetic reader proteins of Leishmania as new drug targets. Several of these targets are being characterised using genetic, proteomic, biochemical and structural techniques. This work has been supported in part by the pharmaceutical company GSK and it is hoped that these targets can be validated using chemical probes from this collaboration. Nathaniel previously worked on protein kinases in Trypanosoma brucei and Toxoplasma gondii, investigating them as potential drug targets and virulence factors.

Giulia Bandini


Giulia is a Centre for Future Health Fellow working on Toxoplasma gondii glycosylation. Her project focuses on the biochemistry and function of nucleocytoplasmic O-fucosylation and on establishing Toxoplasma as a model to study O-glycosylation of intracellular proteins in eukaryotes (click image for more details). After graduating from the University of Padova (Italy) with a degree in Pharmaceutical Biotechnology she completed her PhD in the Ferguson’s lab at University of Dundee, where she studied fucose metabolism in Trypanosoma brucei. During her time at Boston University she shifted her focus to glycan biosynthesis in Toxoplasma.